KLOW 80MG
$104.99
KLOW 80mg is a high-purity peptide research blend commonly studied for skin rejuvenation, collagen support, and regenerative research applications. Supplied as a lyophilized laboratory-grade formulation intended for scientific research use only.
📄 Click Here To See The Certificate
- Studied for its potential role in tissue repair and regenerative research.
- Investigated in laboratory studies involving inflammatory response and immune regulation.
- Commonly used in research on collagen synthesis, wound healing, and cellular recovery.
- Explored for the combined biological activity of GHK-Cu, BPC-157, TB-500, and KPV.
- GHK-Cu (Copper Tripeptide-1): 50mg
- BPC-157: 10mg
- TB-500 (Thymosin Beta-4 Fragment): 10mg
- KPV (Lys-Pro-Val): 10mg
- Total Strength: 80mg
- Purity: ≥99% (HPLC Tested)
- Form: Lyophilised Multi-Peptide Blend
- 1 × Sterile vial containing KLOW 80mg Multi-Peptide Blend
- Tamper-evident protective cap
- Lyophilised powder for laboratory reconstitution
- Secure protective packaging
- Compound Name: KLOW 80mg Multi-Peptide Blend
- Chemical Classification: Synthetic multi-peptide research formulation
- Composition:
- GHK-Cu (Copper Tripeptide-1): Gly-His-Lys complexed with Copper (Cu²⁺)
- BPC-157: Synthetic pentadecapeptide
- TB-500: Synthetic fragment of Thymosin Beta-4
- KPV: Lys-Pro-Val tripeptide
- Structure: Proprietary blend of four high-purity bioactive peptides supplied as a lyophilised powder for laboratory research applications only.
Related products
GHK-Cu 50MG
GHRP-2 10MG
GHRP-2 5MG
GHRP-6 10MG
MOTS-c 10mg
MOTS-c 20mg
MOTS-c 20mg is a premium mitochondria-derived peptide widely researched for its role in cellular energy regulation, metabolic homeostasis, exercise-response signaling, and healthy aging pathways. Often described in research literature as an “exercise mimetic,” MOTS-c has gained major attention for its interaction with AMPK activation and mitochondrial stress-response mechanisms. Supplied as a high-purity 20mg lyophilized peptide for laboratory research use only.
